Shaoyuan Wang

480 total citations
50 papers, 256 citations indexed

About

Shaoyuan Wang is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Shaoyuan Wang has authored 50 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Hematology and 12 papers in Immunology. Recurrent topics in Shaoyuan Wang's work include Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (6 papers) and RNA Interference and Gene Delivery (3 papers). Shaoyuan Wang is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (6 papers) and RNA Interference and Gene Delivery (3 papers). Shaoyuan Wang collaborates with scholars based in China, United States and Canada. Shaoyuan Wang's co-authors include Lili Pan, Zheng Hu, Chengyi Wang, Ying Guo, Yang Li, Du Bin, Yi Wang, Yusheng Chen, Jiucun Wang and Yang Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Frontiers in Immunology.

In The Last Decade

Shaoyuan Wang

44 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoyuan Wang China 9 122 52 50 48 36 50 256
Weina Zhang China 11 173 1.4× 78 1.5× 74 1.5× 37 0.8× 68 1.9× 27 362
Katy Billot France 11 172 1.4× 31 0.6× 59 1.2× 62 1.3× 51 1.4× 15 292
Askar Obulkasim Netherlands 9 137 1.1× 52 1.0× 98 2.0× 22 0.5× 28 0.8× 15 241
Liora Z. Strichman-Almashanu United States 6 289 2.4× 40 0.8× 28 0.6× 26 0.5× 38 1.1× 7 378
Deepak Raina India 6 175 1.4× 66 1.3× 17 0.3× 38 0.8× 48 1.3× 16 293
Qing Lan United States 11 108 0.9× 24 0.5× 27 0.5× 49 1.0× 48 1.3× 31 248
Biyu Zhang China 10 218 1.8× 48 0.9× 59 1.2× 85 1.8× 80 2.2× 23 342
Tupitsyn Nn Russia 7 43 0.4× 46 0.9× 21 0.4× 50 1.0× 87 2.4× 74 195
Bing Long China 8 146 1.2× 63 1.2× 21 0.4× 13 0.3× 33 0.9× 26 278
Stefanie Scheid Germany 9 228 1.9× 24 0.5× 26 0.5× 22 0.5× 34 0.9× 14 333

Countries citing papers authored by Shaoyuan Wang

Since Specialization
Citations

This map shows the geographic impact of Shaoyuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoyuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoyuan Wang more than expected).

Fields of papers citing papers by Shaoyuan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoyuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoyuan Wang. The network helps show where Shaoyuan Wang may publish in the future.

Co-authorship network of co-authors of Shaoyuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoyuan Wang. A scholar is included among the top collaborators of Shaoyuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoyuan Wang. Shaoyuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Min, Zhen Jin, Yang Li, et al.. (2025). Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol. Future Oncology. 21(8). 953–958. 2 indexed citations
2.
Pan, Lili, et al.. (2024). Clinical features and management of germline CEBPA-mutated carriers. Leukemia Research. 138. 107453–107453. 2 indexed citations
3.
Tong, Hongyan, Sujun Gao, Wei Yang, et al.. (2023). Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML). Blood. 142(Supplement 1). 1859–1859. 4 indexed citations
6.
Chen, Zhixiang, Xuechun Wang, Xiaolin Lai, et al.. (2023). Dhx regulates zebrafish intestinal development through the Wnt signaling pathway. Genomics. 115(2). 110578–110578. 4 indexed citations
7.
Wang, Shaoyuan, et al.. (2022). Research on single image super-resolution algorithm based on region perception. 33. 5748–5753. 1 indexed citations
8.
Chen, Xianglei, et al.. (2022). RNA helicase DHX15 decreases cell apoptosis by NF-κB signaling pathway in Burkitt lymphoma. Cancer Cell International. 22(1). 92–92. 4 indexed citations
9.
Schroeder, Jocelyn A., Weiqing Jing, Calvin B. Williams, et al.. (2022). Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis. Frontiers in Immunology. 13. 1029356–1029356. 3 indexed citations
10.
Pan, Lili, Chao Hong, Lai N. Chan, et al.. (2021). PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis. Proceedings of the National Academy of Sciences. 118(7). 13 indexed citations
11.
Li, Ran, Ying Lin, Yu Wang, et al.. (2021). Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry. Frontiers in Oncology. 11. 620989–620989. 18 indexed citations
12.
Chen, Xianglei, Yi Zheng, Qiao Liu, et al.. (2018). Prognostic value and susceptibility of BAX rs4645878 polymorphism in cancer. Medicine. 97(29). e11591–e11591. 13 indexed citations
13.
Cui, Cheng, Xiaohong Tian, Min Su, et al.. (2018). In vivo administration of recombinant BTNL2-Fc fusion protein ameliorates graft-versus-host disease in mice. Cellular Immunology. 335. 22–29. 6 indexed citations
14.
Yan, Fei, Jidong Liu, Xiangmin Zhao, et al.. (2015). Association of the Number of Years Since Menopause with Metabolic Syndrome and Insulin Resistance in Chinese Urban Women. Journal of Women s Health. 24(10). 843–848. 16 indexed citations
15.
Cai, Qian, Merrill A. Biel, Chuan Wang, et al.. (2014). Id1 and NF-κB promote the generation of CD133+ and BMI-1+ keratinocytes and the growth of xenograft tumors in mice. International Journal of Oncology. 44(5). 1481–1489. 4 indexed citations
16.
Pan, Lili, et al.. (2014). Positional cloning and next-generation sequencing identified a TGM6 mutation in a large Chinese pedigree with acute myeloid leukaemia. European Journal of Human Genetics. 23(2). 218–223. 12 indexed citations
17.
Chen, Lulu, et al.. (2013). Protein expression and subcellular localization of familial acute myelogenous leukemia-related factor. Oncology Reports. 30(6). 2672–2676. 3 indexed citations
19.
Wang, Shaoyuan, Shaoxiong Wang, Jinfeng Zhu, et al.. (2008). CD40L-mediated inhibition of NF- kappa B in CA46 Burkitt lymphoma cells promotes apoptosis. Leukemia & lymphoma. 49(9). 1792–1799. 5 indexed citations
20.
Wang, Shaoyuan, et al.. (2004). [Expression of antigen CD40 and survivin gene and their clinical implications in acute myeloid leukemia].. PubMed. 43(10). 769–72. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026